Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02826772
Recruitment Status : Active, not recruiting
First Posted : July 11, 2016
Last Update Posted : July 29, 2019
Information provided by (Responsible Party):
Suzhou Kintor Pharmaceutical Inc,

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : December 2019